Evidence map›Paper›PMID 26554586›Full record

ArticlePloS one2015

Partner Notification for Reduction of HIV-1 Transmission and Related Costs among Men Who Have Sex with Men: A Mathematical Modeling Study.

Brooke E Nichols, Hannelore M Götz, Eric C M van Gorp, Annelies Verbon, Casper Rokx, Charles A B Boucher, David A M C van de Vijver

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Brooke E NicholsDepartment of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
Hannelore M GötzDepartment Infectious Disease Control, Public Health Service Rotterdam-Rijnmond, Rotterdam, the Netherlands.
Eric C M van GorpDepartment of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
Annelies VerbonDepartment of Internal Medicine and Infectious Diseases, Erasmus Medical Center, Rotterdam, the Netherlands.
Casper RokxDepartment of Internal Medicine and Infectious Diseases, Erasmus Medical Center, Rotterdam, the Netherlands.
Charles A B BoucherDepartment of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
David A M C van de VijverDepartment of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
Erasmus MC · NLGGD Rotterdam-Rijnmond · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarlier antiretroviral treatment initiation prevents new HIV infections. A key problem in HIV prevention and care is the high number of patients diagnosed late, as these undiagnosed patients can continue forward HIV transmission. We modeled the impact on the Dutch men-who-have-sex-with-men (MSM) HIV epidemic and cost-effectiveness of an existing partner notification process for earlier identification of HIV-infected individuals to reduce HIV transmission.

methodsReduction in new infections and cost-effectiveness ratios were obtained for the use of partner notification to identify 5% of all new diagnoses (Scenario 1) and 20% of all new diagnoses (Scenario 2), versus no partner notification. Costs and quality adjusted life years (QALYs) were assigned to each disease state and calculated over 5 year increments for a 20 year period.

resultsPartner notification is predicted to avert 18-69 infections (interquartile range [IQR] 13-24; 51-93) over the course of 5 years countrywide to 221-830 (IQR 140-299; 530-1,127) over 20 years for Scenario 1 and 2 respectively. Partner notification was considered cost-effective in the short term, with increasing cost-effectiveness over time: from €41,476 -€41, 736 (IQR €40,529-€42,147; €40,791-€42,397) to €5,773 -€5,887 (€5,134-€7,196; €5,411-€6,552) per QALY gained over a 5 and 20 year period, respectively. The full monetary benefits of partner notification by preventing new HIV infections become more apparent over time.

conclusionsPartner notification will not lead to the end of the HIV epidemic, but will prevent new infections and be increasingly cost-effectiveness over time.

Indexed as

Homosexuality, MaleModels, TheoreticalRisk Reduction BehaviorSexual PartnersAdultContact TracingCost-Benefit AnalysisHIV InfectionsHumansMaleNetherlandsQuality-Adjusted Life Years

Identifiers

PMID26554586
PMCPMC4640527
OpenAlexW2177272990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.